The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Use In Pregnancy & Lactation
There are no data in pregnant women using lorlatinib. Lorlak may cause fetal harm when administered to a pregnant woman. Lorlak is not recommended during pregnancy or for women of childbearing potential not using contraception. Lorlak should not be used during breastfeeding. Male fertility may be compromised during treatment with Lorlak. It is not known whether Lorlak affects female fertility.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
